MADE in America Act to Fuel Life Sciences Industry Growth, Enhance American Independence

OpEd published courtesy of Gannett/Greenville News

Patients in the U.S. have faced drug shortages for years.  This was illustrated amid the current pandemic, which was exacerbated by shortages of PPE, testing ingredients and drugs required for COVID-19 treatment.  Although America remains the world’s top innovator in life sciences, it dramatically lags countries such as China and India in the manufacture of antibiotics, active pharmaceutical ingredients formulated into tablets, capsules and medicines (API), vitamin C, many medical devices and PPE.

 

While South Carolina reaps extraordinary benefits from foreign investment by international manufacturers that contribute significantly to our economy and quality of life, returning the manufacturing and sourcing of life sciences products to our country is not only a powerful economic development driver – it’s a path to national and global stability.   Read on for full article here.